Angiodynamics (ANGO) Treasury Shares (2011 - 2026)

Angiodynamics has reported Treasury Shares for 15 years, with the latest figure at $7.4 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares changed 0.0% year-over-year to $7.4 million; the trailing twelve-month figure through Feb 2026 stood at $7.4 million (changed 0.0% YoY), and the FY2025 full-year result was $7.4 million, up 29.17% from the prior year.
• Treasury Shares for Q1 2026 stood at $7.4 million, roughly flat from $7.4 million in the prior quarter.
• The five-year high for Treasury Shares was $613.8 million in Q4 2024, with the low at $243847.0 in Q1 2025.
• Historically, Treasury Shares has averaged $214.7 million across 5 years, with a median of $370.0 million in 2022.
• Annual changes were most pronounced in 2022 — Treasury Shares changed 0.0% — and 2024, when it increased 29.17%.
• Angiodynamics' Treasury Shares stood at $5.7 million in 2022, then changed by 0.0% to $5.7 million in 2023, then grew by 29.17% to $7.4 million in 2024, then changed by 0.0% to $7.4 million in 2025, then changed by 0.0% to $7.4 million in 2026.
• The last three Treasury Shares figures came in at $7.4 million (Q1 2026), $7.4 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.